Other accrued liabilities
Idexx Laboratories Other accrued liabilities decreased by 1.6% to $112.45M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.7%, from $169.54M to $112.45M. Over 5 years (FY 2020 to FY 2025), Other accrued liabilities shows relatively stable performance with a 0.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A sudden increase may indicate rising operational overhead or pending settlements, while stability suggests predictable expense management.
Detailed definition
This captures miscellaneous short-term obligations that do not fall into specific categories like accounts payable or ac...
Peer comparison
Standard across all capital-intensive industries as a residual category for miscellaneous payables.
other_other_accrued_liabilities_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $112.39M | $124.47M | $133.98M | $124.63M | $158.62M | $145.94M | $149.45M | $123.61M | $115.68M | $107.59M | $113.60M | $125.58M | $166.92M | $175.40M | $165.55M | $169.54M | $90.05M | $94.11M | $114.33M | $112.45M |
| QoQ Change | — | +10.7% | +7.6% | -7.0% | +27.3% | -8.0% | +2.4% | -17.3% | -6.4% | -7.0% | +5.6% | +10.6% | +32.9% | +5.1% | -5.6% | +2.4% | -46.9% | +4.5% | +21.5% | -1.6% |
| YoY Change | — | — | — | — | +41.1% | +17.2% | +11.5% | -0.8% | -27.1% | -26.3% | -24.0% | +1.6% | +44.3% | +63.0% | +45.7% | +35.0% | -46.1% | -46.3% | -30.9% | -33.7% |
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's other accrued liabilities?
- Idexx Laboratories (IDXX) reported other accrued liabilities of $112.45M in Q1 2026.
- How has Idexx Laboratories's other accrued liabilities changed year-over-year?
- Idexx Laboratories's other accrued liabilities decreased by 33.7% year-over-year, from $169.54M to $112.45M.
- What is the long-term trend for Idexx Laboratories's other accrued liabilities?
- Over 5 years (2020 to 2025), Idexx Laboratories's other accrued liabilities has grown at a 0.3% compound annual growth rate (CAGR), from $112.53M to $114.33M.
- What does other accrued liabilities mean?
- A catch-all category for various small, short-term debts owed to third parties.